Olov Wålinder

624 total citations
30 papers, 518 citations indexed

About

Olov Wålinder is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Organic Chemistry. According to data from OpenAlex, Olov Wålinder has authored 30 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Organic Chemistry. Recurrent topics in Olov Wålinder's work include Mechanisms of cancer metastasis (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Magnesium Alloys: Properties and Applications (3 papers). Olov Wålinder is often cited by papers focused on Mechanisms of cancer metastasis (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Magnesium Alloys: Properties and Applications (3 papers). Olov Wålinder collaborates with scholars based in Sweden and United States. Olov Wålinder's co-authors include Lorentz Engström, Örjan Zetterqvist, F. Anders Karlsson, Bengt Westermark, Lars Rask, Bror Edlund, Kjell Öberg, Leif Wide, Henrik Boström and G. Lundqvist and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and FEBS Letters.

In The Last Decade

Olov Wålinder

30 papers receiving 466 citations

Peers

Olov Wålinder
J L Palmer United States
J. Stuart Woodhead United Kingdom
E. Cama United States
Björn Forsgren Sweden
Allan M. Green United States
Glen Teshima United States
Nahed K. Ahmed United States
James D. Craik Kuwait
William S. Mellon United States
Robert D. Litwiller United States
J L Palmer United States
Olov Wålinder
Citations per year, relative to Olov Wålinder Olov Wålinder (= 1×) peers J L Palmer

Countries citing papers authored by Olov Wålinder

Since Specialization
Citations

This map shows the geographic impact of Olov Wålinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olov Wålinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olov Wålinder more than expected).

Fields of papers citing papers by Olov Wålinder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olov Wålinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olov Wålinder. The network helps show where Olov Wålinder may publish in the future.

Co-authorship network of co-authors of Olov Wålinder

This figure shows the co-authorship network connecting the top 25 collaborators of Olov Wålinder. A scholar is included among the top collaborators of Olov Wålinder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olov Wålinder. Olov Wålinder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wålinder, Olov, et al.. (2004). [A case report of systemic capillary leak syndrome. Effective treatment with immunoadsorption and leukotriene antagonist].. PubMed. 101(38). 2880–2. 8 indexed citations
2.
Nordström, Lennart, et al.. (1998). Metabolic control and pregnancy outcome among women with insulin-dependent diabetes mellitus. Acta Obstetricia Et Gynecologica Scandinavica. 77(3). 284–289. 10 indexed citations
3.
Wålinder, Olov, et al.. (1986). Studies of Drug-treated Diabetes in the County of Jämtland, Sweden, Based on Prescription of Insulin and Oral Antidiabetic Drugs. Upsala Journal of Medical Sciences. 91(1). 89–98. 3 indexed citations
4.
Wålinder, Olov, et al.. (1982). New spectrophotometric method for the determination of hemoglobin A1 compared with a microcolumn technique.. Clinical Chemistry. 28(1). 96–99. 13 indexed citations
5.
Ewald, Uwe, Torsten Tuvemo, B. Vessby, & Olov Wålinder. (1982). SERUM APOLIPOPROTEINS A‐I, A‐II AND B IN DIABETIC CHILDREN AND MATCHED HEALTHY CONTROLS. Acta Paediatrica. 71(1). 15–18. 13 indexed citations
6.
Öberg, Kjell, Olov Wålinder, Henrik Boström, G. Lundqvist, & Leif Wide. (1982). Peptide hormone markers in screening for endocrine tumors in multiple endocrine adenomatosis type I. The American Journal of Medicine. 73(5). 619–630. 42 indexed citations
7.
Karlsson, F. Anders, Per Anders Dahlberg, & Olov Wålinder. (1981). Activation of membrane-bound adenylcyclase by thyroid stimulating antibodies. European Journal of Endocrinology. 97(1). 60–66. 7 indexed citations
8.
Tuvemo, Torsten, L Wibell, & Olov Wålinder. (1980). [Hemoglobin AI - a new aid in the control of diabetes].. PubMed. 77(34). 2790–4. 1 indexed citations
9.
Wålinder, Olov, L Wibell, & Torsten Tuvemo. (1980). Relation between hemoglobin AI and determinations of glucose in diabetics treated with and without insulin.. PubMed. 6(4). 251–5. 6 indexed citations
10.
Gunnarsson, R, Dag Nyman, Olov Wålinder, & Jan Östman. (1980). Fibrinolytic Activity and Diabetes Control—Evidence for a Relationship. Acta Medica Scandinavica. 208(S639). 23–24. 8 indexed citations
11.
Tuvemo, Torsten, Uwe Ewald, & Olov Wålinder. (1979). Does good diabetic control influence serum lipids or platelet function in diabetic children?. Pediatric Research. 13(10). 1197–1197. 2 indexed citations
12.
Wålinder, Olov, F. Anders Karlsson, & Per Anders Dahlberg. (1979). ADENYL CYCLASE ACTIVITY IN HUMAN THYROID PLASMA MEMBRANES FROM NORMAL HUMAN THYROID TISSUE AND THYROID ADENOMAS. European Journal of Endocrinology. 92(1). 95–104. 4 indexed citations
13.
Westermark, Bengt, F. Anders Karlsson, & Olov Wålinder. (1979). Thyrotropin is not a growth factor for human thyroid cells in culture. Proceedings of the National Academy of Sciences. 76(4). 2022–2026. 81 indexed citations
14.
Wålinder, Olov, Sver­ker Ljunghall, & L Wibell. (1978). Urinary excretion of cyclic AMP in hyperparathyroidism.. PubMed. 12(1). 67–71. 7 indexed citations
15.
Edlund, Bror & Olov Wålinder. (1974). Evidence for an intermediary phosphorylation of nucleoside diphosphate kinase from pea seed. FEBS Letters. 38(2). 225–228. 6 indexed citations
16.
Wålinder, Olov. (1972). Calf brain phosvitin kinase. Biochimica et Biophysica Acta (BBA) - Enzymology. 258(2). 411–421. 18 indexed citations
17.
Wålinder, Olov, Erik von Sydow, Thomas Popoff, et al.. (1969). Evidence of the Presence of 1-Phosphohistidine as the Main Phosphorylated Component at the Active Site of Bovine Liver Nucleoside Diphosphate Kinase.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 23(1). 339–341. 13 indexed citations
18.
Wålinder, Olov, Örjan Zetterqvist, & Lorentz Engström. (1969). Intermediary Phosphorylation of Bovine Liver Nucleoside Diphosphate Kinase. Journal of Biological Chemistry. 244(4). 1060–1064. 39 indexed citations
19.
20.
Wålinder, Olov, Örjan Zetterqvist, & Lorentz Engström. (1968). Purification of a Bovine Liver Protein Rapidly Phosphorylated by Adenosine Triphosphate. Journal of Biological Chemistry. 243(10). 2793–2798. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J L Palmer Breakdown of academic impact, for papers by J. Stuart Woodhead Breakdown of academic impact, for papers by E. Cama Breakdown of academic impact, for papers by Björn Forsgren Breakdown of academic impact, for papers by Allan M. Green Breakdown of academic impact, for papers by Glen Teshima Breakdown of academic impact, for papers by Nahed K. Ahmed Breakdown of academic impact, for papers by James D. Craik Breakdown of academic impact, for papers by William S. Mellon Breakdown of academic impact, for papers by Robert D. Litwiller
Rankless by CCL
2026